4
8.45
-0.16 (-1.86%)
| Penutupan Terdahulu | 8.61 |
| Buka | 8.52 |
| Jumlah Dagangan | 153,403 |
| Purata Dagangan (3B) | 817,040 |
| Modal Pasaran | 482,791,392 |
| Harga / Jualan (P/S) | 3.95 |
| Harga / Buku (P/B) | 1.17 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 20 Mar 2026 |
| Margin Operasi (TTM) | -383,007.15% |
| EPS Cair (TTM) | -3.18 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -50.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 5.08% |
| Nisbah Semasa (MRQ) | 12.36 |
| Aliran Tunai Operasi (OCF TTM) | -153.26 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -90.21 M |
| Pulangan Atas Aset (ROA TTM) | -22.18% |
| Pulangan Atas Ekuiti (ROE TTM) | -32.97% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | 4D Molecular Therapeutics, Inc. | Menaik | Menaik |
AISkor Stockmoo
0.9
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.88 |
|
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 3.88% |
| % Dimiliki oleh Institusi | 95.91% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Novo Holdings A/S | 31 Dec 2025 | 3,650,737 |
| Evergreen Quality Fund Gp, Ltd. | 31 Dec 2025 | 951,474 |
| Julat 52 Minggu | ||
| Median | 33.00 (290.53%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Barclays | 28 Jan 2026 | 33.00 (290.53%) | Beli | 8.60 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 17 Jan 2026 | Pengumuman | 4DMT Announces New Employment Inducement Grants |
| 07 Jan 2026 | Pengumuman | 4DMT Provides Company Update and Anticipated Development Milestones for 2026 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |